Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
101.85B | 101.89B | 99.46B | 110.67B | 112.94B | 109.71B | Gross Profit |
25.73B | 28.14B | 27.61B | 31.68B | 32.48B | 30.20B | EBIT |
48.00M | 625.00M | 710.00M | 1.10B | 2.46B | 627.00M | EBITDA |
2.67B | 3.62B | 3.57B | 3.95B | 5.00B | 3.15B | Net Income Common Stockholders |
-1.83B | 451.00M | 205.00M | 368.00M | 878.00M | -220.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.49B | 6.03B | 5.35B | 6.15B | 7.72B | 7.18B | Total Assets |
58.60B | 58.19B | 54.26B | 49.37B | 50.90B | 50.28B | Total Debt |
14.02B | 15.58B | 10.42B | 5.29B | 5.48B | 6.52B | Net Debt |
7.53B | 9.96B | 5.06B | -853.00M | -2.24B | -661.00M | Total Liabilities |
31.40B | 29.33B | 25.63B | 20.56B | 22.17B | 22.12B | Stockholders Equity |
27.20B | 28.86B | 28.63B | 28.81B | 28.73B | 28.16B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.79B | -4.37B | -887.00M | 1.27B | 357.00M | Operating Cash Flow |
0.00 | 1.63B | 1.93B | 2.25B | 5.69B | 3.38B | Investing Cash Flow |
0.00 | -3.54B | -7.13B | -3.11B | -3.60B | -2.43B | Financing Cash Flow |
0.00 | 2.60B | 4.40B | -699.00M | -1.55B | -136.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.47B | 7.00 | 2.38% | 15.66% | 2.87% | ||
77 Outperform | ¥9.13B | 9.28 | 4.31% | 2.42% | 154.96% | ||
76 Outperform | ¥11.55B | 11.00 | 1.55% | 6.01% | -21.51% | ||
70 Outperform | ¥10.96B | 6.93 | 1.47% | 0.19% | 32.51% | ||
65 Neutral | $8.88B | 15.03 | 4.75% | 203.74% | 3.58% | -2.49% | |
55 Neutral | ¥12.30B | ― | 2.39% | 0.65% | -679.30% | ||
41 Neutral | ¥10.15B | ― | ― | -5.60% | -23.60% |